Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inspire Medical Systems (INSP)
NYSE:INSP
RESEARCH TOOLSreports
Holding INSP?
Track your performance easily
INSP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$123.00 - $257.40
Previous Close$199.32
Volume594.58K
Average Volume (3M)600.76K
Market Cap
$5.97B
Enterprise Value$5.59B
Total Cash (Recent Filing)$410.99M
Total Debt (Recent Filing)$25.22M
Price to Earnings (P/E)185.2
Beta0.79
Next Earnings
Feb 11, 2025EPS Estimate
$0.72Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.08
Shares Outstanding29,966,914
10 Day Avg. Volume553,302
30 Day Avg. Volume600,762
Standard Deviation0.16
R-Squared0.19
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)7.95
Price to Sales (P/S)6.98
Price to Cash Flow (P/CF)25.20
P/FCF Ratio29.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.39
Enterprise Value/Gross Profit10.58
Enterprise Value/Ebitda144.86
Forecast
1Y Price Target
$236.55Price Target Upside18.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
Inspire Medical Systems News
Bulls Say, Bears Say
Bulls Say
Market Dominance And Competitive EdgeIt is believed that it will be challenging for emerging competitors to disrupt INSP's stronghold on this commercial market.
Revenue And EPS GrowthINSP remains a best-in-class idea after the company delivered another revenue/EPS beat/raise with +33% revenue growth and confirmed FY25 CNS revenue growth estimates.
Stock Buyback And Financial OutlookINSP is even buying back stock, which is a bullish sign for margins and free cash flow outlook.
Bears Say
Competitive LandscapeCompetitor LIVN's OSPREY data in obstructive sleep apnea (OSA) showed similar AHI and ODI reductions to those seen in INSP's pivotal studies, but included patients with complete concentric collapse, potentially indicating a competitive advantage for LIVN.
Market RisksAnticipation of tirzepatide approval in OSA by the end of the year represents a near-term commercial risk for INSP.
Sales OutlookQ4 sales outlook is slightly softer due to headwinds from hurricanes and IV shortage.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
INSP FAQ
What was Inspire Medical Systems’s price range in the past 12 months?
Inspire Medical Systems lowest stock price was $123.00 and its highest was $257.40 in the past 12 months.
What is Inspire Medical Systems’s market cap?
Currently, no data Available
When is Inspire Medical Systems’s upcoming earnings report date?
Inspire Medical Systems’s upcoming earnings report date is Feb 11, 2025 which is in 77 days.
How were Inspire Medical Systems’s earnings last quarter?
Inspire Medical Systems released its earnings results on Nov 04, 2024. The company reported $0.6 earnings per share for the quarter, beating the consensus estimate of $0.061 by $0.539.
Is Inspire Medical Systems overvalued?
According to Wall Street analysts Inspire Medical Systems’s price is currently Undervalued.
Does Inspire Medical Systems pay dividends?
Inspire Medical Systems does not currently pay dividends.
What is Inspire Medical Systems’s EPS estimate?
Inspire Medical Systems’s EPS estimate is $0.72.
How many shares outstanding does Inspire Medical Systems have?
Inspire Medical Systems has 29,966,913 shares outstanding.
What happened to Inspire Medical Systems’s price movement after its last earnings report?
Inspire Medical Systems reported an EPS of $0.6 in its last earnings report, beating expectations of $0.061. Following the earnings report the stock price went up 3.264%.
Which hedge fund is a major shareholder of Inspire Medical Systems?
Among the largest hedge funds holding Inspire Medical Systems’s share is Gilder Gagnon Howe & Co LLC.. It holds Inspire Medical Systems’s shares valued at 47M.
---
Inspire Medical Systems Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$236.55 (18.68% Upside)
$236.55 (18.68% Upside)
Blogger Sentiment
Bullish
INSP Sentiment 75%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 305.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 0.9%
Last 30 Days ▲ 0.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.09%
12-Months-Change
Fundamentals
Return on Equity
5.33%
Trailing 12-Months
Asset Growth
24.50%
Trailing 12-Months
Company Description
Inspire Medical Systems
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
---
INSP Company Deck
---
INSP Earnings Call
Q3 2024
0:00 / 0:00
---
INSP Revenue Breakdown
97.02% U.S.
2.98% Other
---
INSP Stock 12 Month Forecast
Average Price Target
$236.55
▲(18.68% Upside)
Technical Analysis
Best Analysts Covering INSP
1 Year
1 Year Success Rate
18/28 ratings generated profit
1 Year Average Return
+24.57%
assigned a buy rating 22 days ago
Copying Adam Maeder's trades and holding each position for 1 Year would result in 64.29% of your transactions generating a profit, with an average return of +24.57% per trade.
---